Vol 9 Issue 5

Download PDF

Featuring

Issue Spotlight: Gene delivery platform evolution Part 2: Non-viral
Upstream processing
Other articles
Webinars

Gene delivery platform evolution Part 2: Non-viral

Guest Editor:

Lynn Zechiedrich, Kyle & Josephine Morrow Chair & Professor in Molecular Virology & Microbiology at Baylor College of Medicine

Interview

LNPs and beyond: nanoscale delivery systems in advanced therapy applications

Shashank Pinnapireddy

17 May 2023

Read

Podcast

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Valeria Annibaldi, Andrea Toell

29 May 2023

Listen

Upstream processing

FastFacts

A large-scale lentivirus manufacturing platform to accelerate time to clinic

Brian Mullan, Brian Dutra

30 August 2023

Read

Journal articles

Interview

Investing long-term in the cell & gene therapies of the future

Geeta Vemuri

26 March 2023

Read

Cell therapy workflows: improving reproducibility and simplifying compliance efforts with batch centrifugation solutions

Atalay Tok

31 May 2023

Watch

Improving AAV and LV upstream manufacturing using cGMP lipid polymer nanocomplexes (LPNCs)

Leisha Kopp

1 June 2023

Watch

Optimizing the cell therapy patient journey through integrated CRO/CDMO partnership

Panteli Theocharous, Rupa Pike

6 June 2023

Watch

How to increase speed from project initiation to IND filing for CGT products

Jennifer Cheung

8 June 2023

Watch

How can the gene therapy industry drive down the cost of goods to better serve patients?

Emmanuelle Cameau

13 June 2023

Watch

Enabling RNA therapeutics: innovative cationic lipids to improve LNP formulation

C Gueguen, M Hellal, J Depollier

14 June 2023

Watch

Overcoming upstream and downstream process barriers for large scale AAV production

B Woo PhD, A Miller, J Zmuda PhD

15 June 2023

Watch

Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV-MAX Production System

Jonathan Zmuda PhD

20 June 2023

Watch

CELL AND GENE THERAPY INSIGHTS

June 2023 Issue

Vol 9 Issue 5

Featuring

SPOTLIGHT

Gene delivery platform evolution Part 2: Non-viral

Interview

LNPs and beyond: nanoscale delivery systems in advanced therapy applications

Podcast

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Vectors FOCUS

Upstream processing

FastFacts

A large-scale lentivirus manufacturing platform to accelerate time to clinic

Journal articles

Interview

Investing long-term in the cell & gene therapies of the future

Webinars

Cell therapy workflows: improving reproducibility and simplifying compliance efforts with batch centrifugation solutions

Improving AAV and LV upstream manufacturing using cGMP lipid polymer nanocomplexes (LPNCs)

Optimizing the cell therapy patient journey through integrated CRO/CDMO partnership

How to increase speed from project initiation to IND filing for CGT products

How can the gene therapy industry drive down the cost of goods to better serve patients?

Enabling RNA therapeutics: innovative cationic lipids to improve LNP formulation

Overcoming upstream and downstream process barriers for large scale AAV production

Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV-MAX Production System

How reducing labor time can save on your cell therapy manufacturing costs

A shortcut through process development for CAR-T cell manufacturing

Accelerate your AAV process development with a new-wave analytical tool

CELL AND GENE THERAPY INSIGHTS

June 2023 Issue

Vol 9 Issue 5

Featuring

SPOTLIGHT

Gene delivery platform evolution Part 2: Non-viral

Interview

LNPs and beyond: nanoscale delivery systems in advanced therapy applications

Podcast

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Vectors FOCUS

Upstream processing

FastFacts

A large-scale lentivirus manufacturing platform to accelerate time to clinic

Journal articles

Interview

Investing long-term in the cell & gene therapies of the future

Webinars

Cell therapy workflows: improving reproducibility and simplifying compliance efforts with batch centrifugation solutions

Improving AAV and LV upstream manufacturing using cGMP lipid polymer nanocomplexes (LPNCs)

Optimizing the cell therapy patient journey through integrated CRO/CDMO partnership

How to increase speed from project initiation to IND filing for CGT products

How can the gene therapy industry drive down the cost of goods to better serve patients?

﻿﻿Enabling RNA therapeutics: innovative cationic lipids to improve LNP formulation

Overcoming upstream and downstream process barriers for large scale AAV production﻿

Scalable production of AAV from shake flasks to 1,000 L single use bioreactors using the Gibco™ CTS™ AAV-MAX Production System

How reducing labor time can save on your cell therapy manufacturing costs

A shortcut through process development for CAR-T cell manufacturing

Accelerate your AAV process development with a new-wave analytical tool

Enabling RNA therapeutics: innovative cationic lipids to improve LNP formulation

Overcoming upstream and downstream process barriers for large scale AAV production